Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Joanne E. Cluette-Brown"'
Autor:
M. Rabie Al-Turkmani, Charlotte Andersson, Ragheed Alturkmani, Waddah Katrangi, Joanne E. Cluette-Brown, Steven D. Freedman, Michael Laposata
Publikováno v:
Journal of Lipid Research, Vol 49, Iss 9, Pp 1946-1954 (2008)
Specific fatty acid alterations have been described in the blood and tissues of cystic fibrosis (CF) patients. The principal alterations include decreased levels of linoleic acid (LA) and docosahexaenoic acid (DHA). We investigated the potential mech
Externí odkaz:
https://doaj.org/article/8a4ccc960a3d4d79b7ebe071de0af522
Autor:
Charlotte Andersson, M. Rabie Al-Turkmani, Juanito E. Savaille, Ragheed Alturkmani, Waddah Katrangi, Joanne E. Cluette-Brown, Munir M. Zaman, Michael Laposata, Steven D. Freedman
Publikováno v:
Journal of Lipid Research, Vol 49, Iss 8, Pp 1692-1700 (2008)
Cystic fibrosis (CF) is associated with fatty acid alterations characterized by low linoleic and docosahexaenoic acid. It is not clear whether these fatty acid alterations are directly linked to cystic fibrosis transmembrane conductance regulator (CF
Externí odkaz:
https://doaj.org/article/50b6dc813cc541f4a7978b318249d3cf
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 3, Pp 612-620 (2003)
Although alcohol abuse is known to cause an array of ethanol-induced red blood cell (RBC) abnormalities, the underlying molecular mechanisms remain poorly understood. Fatty acid ethyl esters (FAEEs) are toxic, nonoxidative ethanol metabolites that ha
Externí odkaz:
https://doaj.org/article/75fbb2b5673046449cb6e4f02c62ba3d
Autor:
Hilda V. Gutierrez, George Perides, Joanne E. Cluette-Brown, Duy T. Dao, Ece Bicak, Lady Leidy Sanchez-Fernandez, William Yakah, Douglas Gordon, Elizabeth Pollack, Stefan Ehling, Camilia R. Martin, Arthur Nedder, Olajumoke Akinsulire, Savanna Kiefer, Stephen J. Demichele, Pratibha Singh, Yan Liu, Evelyn Obregon, Lorenzo Anez-Bustillos, Mustafa Vurma, Steven D. Freedman
Publikováno v:
JPEN J Parenter Enteral Nutr
BACKGROUND: Preterm delivery and current nutritional strategies result in deficiencies of critical long chain fatty acids and lipophilic nutrients increasing the risk of preterm morbidities. We sought to determine the efficacy of preventing postnatal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8bd3e141a649a36d2651ceeaa96461
https://doi.org/10.1002/jpen.1697
https://doi.org/10.1002/jpen.1697
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-16 (2018)
Scientific Reports
Scientific Reports
Poor growth in the Neonatal Intensive Care Unit is associated with an increased risk for poor neurodevelopmental outcomes for preterm infants, however the mechanism is unclear. The microbiome has increasingly been recognized as a modifiable environme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d940f59050642b133b7c740faa5418ac
http://link.springer.com/article/10.1038/s41598-018-23692-w
http://link.springer.com/article/10.1038/s41598-018-23692-w
Autor:
Mark Puder, Steven D. Freedman, Munir M. Zaman, Joanne E. Cluette-Brown, Pratibha Singh, Camilia R. Martin, Barbara Stoll, Adesola C. Akinkuotu, Kathleen M. Gura, Michael C. Perillo, Oluyinka O. Olutoye, Doug Burrin
Publikováno v:
Nutrition Research. 39:51-60
Infants with short bowel syndrome (SBS) are at high risk for malabsorption, malnutrition, and failure to thrive. The objective of this study was to evaluate in a porcine model of SBS, the systemic absorption of a novel enteral Docosahexaenoic acid (D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f0473480d461bd437a6f4a5a56bbca
https://doi.org/10.1016/j.nutres.2017.02.004
https://doi.org/10.1016/j.nutres.2017.02.004
Autor:
Munir M. Zaman, Camilia R. Martin, Killimangalam Bhaskar, Nezam H. Afdhal, Paola G. Blanco, Jill C. Keach, S. Gautam, Keith D. Lindor, Joanne E. Cluette-Brown, Steven D. Freedman, Sunil A Sheth, Janice L. Petz
Publikováno v:
Alimentary Pharmacology & Therapeutics. 35:255-265
Aliment Pharmacol Ther 2012; 35: 255–265 Summary Background Primary sclerosing cholangitis (PSC) is characterised by progressive inflammatory and fibrotic destruction of the biliary ducts. There are no effective medical therapies and presently high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb87e0b9bae783fc629e766c3beafeac
https://doi.org/10.1111/j.1365-2036.2011.04926.x
https://doi.org/10.1111/j.1365-2036.2011.04926.x
Autor:
Joanne E. Cluette-Brown, Waddah Katrangi, M. Rabie Al-Turkmani, Michael Laposata, Ragheed Alturkmani, Charlotte Andersson, Steven D. Freedman
Publikováno v:
Journal of Lipid Research, Vol 49, Iss 9, Pp 1946-1954 (2008)
Specific fatty acid alterations have been described in the blood and tissues of cystic fibrosis (CF) patients. The principal alterations include decreased levels of linoleic acid (LA) and docosahexaenoic acid (DHA). We investigated the potential mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6f1e69a6b015573e4ee7b01fce6846
https://doi.org/10.1194/jlr.m800035-jlr200
https://doi.org/10.1194/jlr.m800035-jlr200
Autor:
Waddah Katrangi, Juanito E. Savaille, M. Rabie Al-Turkmani, Munir M. Zaman, Steven D. Freedman, Ragheed Alturkmani, Michael Laposata, Joanne E. Cluette-Brown, Charlotte Andersson
Publikováno v:
Journal of Lipid Research, Vol 49, Iss 8, Pp 1692-1700 (2008)
Cystic fibrosis (CF) is associated with fatty acid alterations characterized by low linoleic and docosahexaenoic acid. It is not clear whether these fatty acid alterations are directly linked to cystic fibrosis transmembrane conductance regulator (CF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9cd666ff96e53af6df70dd7fc9c9a7
https://doi.org/10.1194/jlr.m700388-jlr200
https://doi.org/10.1194/jlr.m700388-jlr200
Autor:
Joseph Biederman, Liisa Hantsoo, Eric Mick, Joanne E. Cluette-Brown, Catherine A. Best, James G. Waxmonsky, Janet Wozniak, Michael Laposata
Publikováno v:
European Neuropsychopharmacology. 17:440-447
To test the effectiveness and safety of omega-3 fatty acids (Omegabrite(R) brand) in the treatment of pediatric bipolar disorder (BPD).Subjects (N=20) were outpatients of both sexes, 6 to 17 years of age, with a DSM-IV diagnosis of BPD and Young Mani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d952dddd2a05031a9c636d2fe8dc7779
https://doi.org/10.1016/j.euroneuro.2006.11.006
https://doi.org/10.1016/j.euroneuro.2006.11.006